Physician

Bernard J Rose, M.D.

According to 2025 Medicare claims, Bernard Rose, M.D. (NPI: 1508864042) practices general practice in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is BEAVERTOWN CLINIC INC (NPI: 1902803703; TIN: 31-0920004) and primary practice location at 45429-4169.

Rose's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 173 traditional Medicare patients, billed 1,150 HCPCS/CPT codes, and received $73,098 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 6,587 prescription claims across 455 beneficiaries totaling $223,295 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2023 DME data shows 11 claims. Open Payments data shows 2 records totaling $39. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and rose steadily, from $1,577 to $2,973.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	248	2,059	$72,787
2016	280	2,287	$86,803
2017	270	3,203	$81,443
2018	264	2,652	$90,274
2019	257	1,992	$83,068
2020	240	2,324	$76,497
2021	215	2,300	$95,632
2022	212	1,621	$94,271
2023	180	1,851	$80,588
2024	173	1,150	$73,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	410	5,451	$215,245
2016	435	5,673	$215,905
2017	474	5,693	$264,349
2018	473	5,928	$276,392
2019	472	6,355	$345,485
2020	460	6,159	$329,903
2021	449	5,924	$356,841
2022	464	6,147	$293,822
2023	441	6,364	$323,815
2024	455	6,587	$223,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	124	$2,857
2016	13	93	$1,170
2017	14	68	$967
2018	11	88	$2,025
2019	N/R	62	$760
2020	N/R	64	$1,434
2021	N/R	40	$1,434
2022	N/R	16	$945
2023	N/R	11	$2,199
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	94	192	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	161	560	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	35	61	$43
G0444	Annual depression screening, 5 to 15 minutes	27	27	$16
36415	Insertion of needle into vein for collection of blood sample	71	98	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	1,920	$39,826
Eliquis	Apixaban	29	1,859	$34,338
Xarelto	Rivaroxaban	13	750	$13,696
Albuterol Sulfate Hfa	Albuterol Sulfate	194	7,084	$5,204
Breo Ellipta	Fluticasone/Vilanterol	12	360	$4,797

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$39	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bernard J. Rose, M.D.?

Tedicare shows public-source Medicare data for Bernard J. Rose, M.D. (NPI 1508864042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bernard J. Rose, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bernard J. Rose, M.D.?

Bernard J. Rose, M.D. is linked to BEAVERTOWN CLINIC INC (billing NPI 1902803703) in the available physician profile data.

Does Bernard J. Rose, M.D. have Open Payments data?

Bernard J. Rose, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.